>1000

Title Average Ratingsort ascending
Chemotherapy of advanced epithelial cancer--a critical review 90.00%
Impact of antioxidant supplementation on chemotherapeutic toxicity: a systematic review of the evidence from randomized ........ 90.00%
Mistletoe therapy in oncology 90.00%
Patient satisfaction with primary care: an observational study comparing anthroposophic and conventional care 90.00%
Randomized Trials of Selenium, Vitamin E, or Vitamin C for Prostate Cancer Prevention 90.00%
The ibogaine medical subculture. 85.00%
Metformin and Cancer Risk in Diabetic Patients: A Systematic Review and Meta-analysis. 80.00%
Metformin use and prostate cancer in Caucasian men: results from a population-based case-control study. 80.00%
Variations of the piriformis and sciatic nerve with clinical consequence: a review 80.00%
Epidemiologic evidence on coffee and cancer. 70.00%
Unconventional anticancer agents: a systematic review of clinical trials. 60.00%
Serum calcium and the risk of prostate cancer. 60.00%
Effects of denosumab on bone mineral density in men receiving androgen deprivation therapy for prostate cancer. 50.00%
Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung Cancer 50.00%
Nadroparin for the prevention of thromboembolic events in ambulatory patients with metastatic or locally advanced solid cancer 50.00%
Real world treatment patterns of gastrointestinal stromal tumor patients. 50.00%
Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities 50.00%
Prediction of Survival following First-Line Chemotherapy in Men with Castration-Resistant Metastatic Prostate Cancer. 50.00%
Long term outcomes following surgical resection of myxopapillary ependymomas. 40.00%
Prostate specific antigen bounce after simultaneous irradiation for prostate cancer: the relationship to patient age. 0.00%
Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer........ 0.00%
WITHDRAWN: Multi-agent chemotherapy for early breast cancer. 0.00%